- Home
- DERM vs NAZ Comparison
DERM vs NAZ Comparison
Compare DERM & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- NAZ
- Stock Information
- Founded
- DERM 2014
- NAZ 1992
- Country
- DERM United States
- NAZ United States
- Employees
- DERM N/A
- NAZ N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- NAZ Finance/Investors Services
- Sector
- DERM Health Care
- NAZ Finance
- Exchange
- DERM Nasdaq
- NAZ Nasdaq
- Market Cap
- DERM 124.4M
- NAZ 135.7M
- IPO Year
- DERM 2021
- NAZ N/A
- Fundamental
- Price
- DERM $5.12
- NAZ $12.21
- Analyst Decision
- DERM Strong Buy
- NAZ
- Analyst Count
- DERM 3
- NAZ 0
- Target Price
- DERM $9.50
- NAZ N/A
- AVG Volume (30 Days)
- DERM 159.2K
- NAZ 18.3K
- Earning Date
- DERM 11-12-2024
- NAZ 01-01-0001
- Dividend Yield
- DERM N/A
- NAZ 3.69%
- EPS Growth
- DERM N/A
- NAZ N/A
- EPS
- DERM 0.04
- NAZ N/A
- Revenue
- DERM $77,681,000.00
- NAZ N/A
- Revenue This Year
- DERM N/A
- NAZ N/A
- Revenue Next Year
- DERM $37.38
- NAZ N/A
- P/E Ratio
- DERM N/A
- NAZ N/A
- Revenue Growth
- DERM 26.38
- NAZ N/A
- 52 Week Low
- DERM $2.85
- NAZ $9.22
- 52 Week High
- DERM $8.11
- NAZ $11.37
- Technical
- Relative Strength Index (RSI)
- DERM 40.57
- NAZ 64.37
- Support Level
- DERM $5.00
- NAZ $11.56
- Resistance Level
- DERM $5.82
- NAZ $13.33
- Average True Range (ATR)
- DERM 0.45
- NAZ 0.23
- MACD
- DERM -0.07
- NAZ 0.06
- Stochastic Oscillator
- DERM 8.99
- NAZ 33.15
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.